312 related articles for article (PubMed ID: 24485372)
1. Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.
Ramanathan S; Johnson S; Burns SP; Kralovic SM; Goldstein B; Smith B; Gerding DN; Evans CT
Am J Infect Control; 2014 Feb; 42(2):168-73. PubMed ID: 24485372
[TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.
McFarland LV; Clarridge JE; Beneda HW; Raugi GJ
Clin Infect Dis; 2007 Nov; 45(9):1141-51. PubMed ID: 17918075
[TBL] [Abstract][Full Text] [Related]
3. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China.
Huang H; Wu S; Chen R; Xu S; Fang H; Weintraub A; Nord CE
Anaerobe; 2014 Dec; 30():65-9. PubMed ID: 25219941
[TBL] [Abstract][Full Text] [Related]
4. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
Gordon D; Young LR; Reddy S; Bergman C; Young JD
J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
[TBL] [Abstract][Full Text] [Related]
6. Predictors of first recurrence of Clostridium difficile infections in children.
Tschudin-Sutter S; Tamma PD; Milstone AM; Perl TM
Pediatr Infect Dis J; 2014 Apr; 33(4):414-6. PubMed ID: 24168983
[TBL] [Abstract][Full Text] [Related]
7. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.
Pakyz AL; Jawahar R; Wang Q; Harpe SE
J Antimicrob Chemother; 2014 Apr; 69(4):1127-31. PubMed ID: 24327619
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile infection in hospitalized cancer patients in Beijing, China is facilitated by receipt of cancer chemotherapy.
Han XH; Du CX; Zhang CL; Zheng CL; Wang L; Li D; Feng Y; DuPont HL; Jiang ZD; Shi YK
Anaerobe; 2013 Dec; 24():82-4. PubMed ID: 23770543
[TBL] [Abstract][Full Text] [Related]
9. Recurrent Clostridium difficile infection is associated with increased mortality.
Olsen MA; Yan Y; Reske KA; Zilberberg MD; Dubberke ER
Clin Microbiol Infect; 2015 Feb; 21(2):164-70. PubMed ID: 25658560
[TBL] [Abstract][Full Text] [Related]
10. Clostridium difficile infection in a long-term care facility: hospital-associated illness compared with long-term care-associated illness.
Kim JH; Toy D; Muder RR
Infect Control Hosp Epidemiol; 2011 Jul; 32(7):656-60. PubMed ID: 21666395
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
Daniel A; Rapose A
J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
[TBL] [Abstract][Full Text] [Related]
12. The prolongation of length of stay because of Clostridium difficile infection.
Mitchell BG; Gardner A; Barnett AG; Hiller JE; Graves N
Am J Infect Control; 2014 Feb; 42(2):164-7. PubMed ID: 24290226
[TBL] [Abstract][Full Text] [Related]
13. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
[TBL] [Abstract][Full Text] [Related]
14. Analysis of interventions to reduce the incidence of Clostridium difficile infection at a London teaching hospital trust, 2003-2011.
Marufu O; Desai N; Aldred D; Brown T; Eltringham I
J Hosp Infect; 2015 Jan; 89(1):38-45. PubMed ID: 25480022
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors and risk for recurrent Clostridium difficile infection.
Linsky A; Gupta K; Lawler EV; Fonda JR; Hermos JA
Arch Intern Med; 2010 May; 170(9):772-8. PubMed ID: 20458084
[TBL] [Abstract][Full Text] [Related]
16. The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010.
Reveles KR; Lee GC; Boyd NK; Frei CR
Am J Infect Control; 2014 Oct; 42(10):1028-32. PubMed ID: 25278388
[TBL] [Abstract][Full Text] [Related]
17. Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control.
Marwick CA; Yu N; Lockhart MC; McGuigan CC; Wiuff C; Davey PG; Donnan PT
J Antimicrob Chemother; 2013 Dec; 68(12):2927-33. PubMed ID: 23825381
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Clostridioides difficile recurrence across a national cohort of veterans in outpatient, acute, and long-term care settings.
Appaneal HJ; Caffrey AR; Beganovic M; Avramovic S; LaPlante KL
Am J Health Syst Pharm; 2019 Apr; 76(9):581-590. PubMed ID: 31361830
[TBL] [Abstract][Full Text] [Related]
19. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.
McDonald EG; Milligan J; Frenette C; Lee TC
JAMA Intern Med; 2015 May; 175(5):784-91. PubMed ID: 25730198
[TBL] [Abstract][Full Text] [Related]
20. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.
Garey KW; Dao-Tran TK; Jiang ZD; Price MP; Gentry LO; Dupont HL
J Hosp Infect; 2008 Oct; 70(2):142-7. PubMed ID: 18723249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
